Blood lipid profile, plasma fatty acid composition and Apo-B100/Apo-A1 ratio were significantly improved by a proposed anti-inflammatory portfolio diet, indicating that adjuvant dietary treatment can be beneficial for CVD prevention in RA, even among pharmacologically well-managed patients. The gene discussed is APOB; the disease is rheumatoid arthritis.